Shanghai OPM Biosciences Co., Ltd. (SHSE: 688293)
Health Care · Biotechnology · CN
CN¥71.50
-10.19% today · +18.3% 1Y
Shanghai OPM Biosciences Co., Ltd. (SHSE: 688293) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.52B.
Over the last twelve months the share price has gained 18.3%, trading between 34.13 and 88.54.
Tweenvest scores Shanghai OPM Biosciences Co., Ltd. across four factors: quality 67/100, value 35/100, growth 91/100, dividend 39/100. Its strongest factor is growth.
688293 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.52B
- Revenue (TTM)
- $92.87M
- P/E
- 108.00
- EPS
- 0.66
- Dividend yield
- 0.60%
- Beta (5Y)
- 0.57
- 52-week high
- CN¥88.54
- 52-week low
- CN¥34.13
- Avg volume (3M)
- —
- Shares outstanding
- 142.19M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Stoke Therapeutics, Inc.NasdaqGS: STOK | $1.60B | $24.45 | -1.17% |
| Mabwell (Shanghai) Bioscience Co., Ltd.SHSE: 688062 | $1.60B | CN¥24.78 | -8.36% |
| uniQure N.V.NasdaqGS: QURE | $1.57B | $21.73 | -3.81% |
| Ultragenyx Pharmaceutical Inc.NasdaqGS: RARE | $1.52B | $15.28 | -1.29% |
| Syndax Pharmaceuticals, Inc.NasdaqGS: SNDX | $1.52B | $16.49 | -2.97% |
| Immunocore Holdings plcNasdaqGS: IMCR | $1.51B | $29.20 | -0.65% |
| Wedge Industrial Co.,Ltd.SZSE: 000534 | $1.50B | CN¥20.79 | -3.88% |
| InventisBio Co., LimitedSHSE: 688382 | $1.49B | CN¥17.26 | -9.49% |
Figures last refreshed Oct 11, 2026.